Home

Artelo Biosciences, Inc. (ARTL)

Evaluation: Based on all recent filings, financial statements, and news.

See full evaluation
Ask a question about Artelo Biosciences, Inc. (ARTL)

Go deeper and ask any question about ARTL

Company Performance

Current Price

as of Sep 13, 2024

$1.18

P/E Ratio

N/A

Market Cap

$3.81M

Description

Artelo Biosciences, Inc. is a clinical stage biopharmaceutical company, which focuses on the development of therapeutics that target lipid-signaling pathways, including the endocannabinoid system. Its product candidate pipeline includes ART27.13-Synthetic Cannabinoid Agonist, ART26.12-FABP5 inhibitor, and ART12.11-Synthetic CBD Cocrystal. The company was founded on May 2, 2011 and is headquartered in Solana Beach, CA.

Metrics

Overview

  • HQSolana Beach, CA
  • SectorHealth Technology
  • IndustryPharmaceuticals: Major
  • TickerARTL
  • Price$1.18+1.72%

Trading Information

  • Market Cap$3.81M
  • Float99.17%
  • Average Daily Volume (1m)7,603
  • Average Daily Volume (3m)82,765
  • EPS-$3.32

Company

  • RevenueN/A
  • Rev Growth (1yr)N/A
  • Net Income-$2.43M
  • Gross MarginN/A
  • EBITDA MarginN/A
  • EBITDA-$2.51M
  • EV-$1.16M
  • EV/RevenueN/A
  • P/EN/A
  • P/SN/A
Documents